Білатеральний синхронний і метахронний рак грудної залози: особливості топографії, етіологія, патогенез, чинники ризику, діагностика і прогноз

Аналіз даних вітчизняної і закордонної фахової літератури, присвяченої патогенезу, особливостям топографії, клінічних та морфологічних проявів, чинникам ризику, діагностики, прогнозу перебігу білатерального синхронного і метахронного раку грудної залози.

Рубрика Медицина
Вид статья
Язык украинский
Дата добавления 24.08.2023
Размер файла 41,2 K

Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже

Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.

61. Singla A., Kaur N., Walia D.S., Singla D. Bilateral Metachronous Breast Carcinoma: A Rare Case Report. Int J Appl Basic Med Res. 2018 Apr-Jun;8(2):126-128.

62. Senkus E., Szade J., Pieczynska B., Zaczek A., Pikiel J., Sosinska-Mielcarek K., et al. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype. Int J Clin Exp Pathol. 2013 Dec 15;7(1):353-63.

63. Ibrahim N.Y., Sroor M.Y., Darwish D.O. Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors. Asian Pac J Cancer Prev. 2015;16(3):1007-10.

64. Howe H.L., Weinstein R., Alvi R., Kohler B., Ellison J.H. Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998. Breast Cancer Res Treat. 2005 Apr;90(3):223-32.

65. Anderson D.E. Genetic study of breast cancer: identification of a high risk group. Cancer. 1974 Oct;34(4):1090-7.

66. Metcalfe K., Lynch H.T., Ghadirian P., Tung N., Olivotto I., Warner E, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004 Jun 15;22(12):2328-35.

67. Verhoog L.C., Brekelmans C.T., Seynaeve C., Meijers-Heijboer E.J., Klijn J.G. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer. 2000 Aug;83(3):384-6.

68. Metcalfe K., Gershman S., Lynch H.T., Ghadirian P., Tung N., Kim-Sing C., et al. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2011;104(9):1384-1392.

69. Narod S.A. Bilateral breast cancers. Nat Rev Clin Oncol. 2014;11(3):157-166.

70. Graeser M.K., Engel C., Rhiem K., Gadzicki D., Bick U., Kast K., et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27(35):5887-5892.

71. Fowble B., Hanlon A., Freedman G., Nicolaou N., Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):679-90.

72. Bergthorsson J.T., Ejlertsen B., Olsen J.H., Borg A., Nielsen K.V., Barkardottir RB, et al. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet. 2001 Jun;38(6):361-8.

73. Eliyatkin N., Zengel B., Yagci A., Comut E., Postaci H., Uslu A., et al. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up. Asian Pac J Cancer Prev. 2015;16(12):4921-6.

74. Heron D.E., Komarnicky L.T., Hyslop T., Schwartz G.F., Mansfield C.M. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88:2739-2750.

75. Baretta Z., Olopade O.I, Huo D. Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers. Breast. 2015;24:131-6.

76. Zhi H., Ou B., Luo B.M., Feng X., Wen Y.L., Yang H.Y. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Ultrasound Med. 2007;26(6):807-15.

77. Murphy T.J., Conant E.F., Hanau C.A., Ehrlich S.M., Feig S.A. Bilateral Breast Carcinoma: Mammographic and Histologic Correlation. Radiology. 1995;195:617-621. PMID: 7753983.

78. Leis HP Jr, Mersheimer W.L., Black M.M., De Chabon A. The second breast. NY State Med. 1965;65:2460-2468.

79. Senofsky G.M., Wanebo H.J., Wilhelm M.C., Pope T.L. Jr, Fechner R.E., Broaddus W, et al. Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? Cancer. 1986;57:597- 602.

80. Roubidoux M.A., Lai N.E., Paramagul C., Joynt L.K., Helvie M.A. Mammographic appearance of cancer in the opposite breast: comparison with the first cancer. AJR Am J Roentgenol. 1996 Jan;166(1):29-31.

81. Lou L., Cong X.L., Yu G.F., Li J.C., Ma Y.X. US findings of bilateral primary breast cancer: retrospective study. Eur J Radiol. 2007 Jan;61(1):154-7.

82. Kim M.J., Kim E.K., Kwak J.Y., Park B.W., Kim S.I., Sohn J., et al. Role of sonography in the detection of contralateral metachronous breast cancer in an Asian population. AJR Am J Roentgenol. 2008 Feb;190(2):476-80.

83. Jacobs M.A., Barker P.B., Bottomley P.A., Bhujwalla Z., Bluemke D.A. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging. 2004;19(1):68-75.

84. Derebek E., Balci P., Alanyali H., Kocdor M.A., Capa G., Gorken I.B., et al. Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging. Clin Nucl Med. 1999;24:590-3.

85. Meladze N.V., Shariya M.A., Ustyuzhanin D.V., Ternovoy S.K. The role of Magnetic Resonance Mammography аnd Magnetic Resonance Spectroscopy іп the differential diagnosis of breast tumors. J Radiol Nucl Med. 2018;99(1):13-22.

Размещено на Allbest.ru

...

Подобные документы

Работы в архивах красиво оформлены согласно требованиям ВУЗов и содержат рисунки, диаграммы, формулы и т.д.
PPT, PPTX и PDF-файлы представлены только в архивах.
Рекомендуем скачать работу.